Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06665542 · ClinicalTrials.gov registry record

A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.

A clinical trial of Sepsis and Acute Infection, sponsored by MeMed Diagnostics.

Active
Registry status
2,000
Enrollment target
8
Study locations

NCT06665542 is a study of Sepsis and Acute Infection that is active but no longer recruiting, run by MeMed Diagnostics. The registered enrollment target is 2,000 participants, below the 6,542-participant average among 90 other Sepsis trials with a reported enrollment target (69% lower). The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06665542, a study of Sepsis and Acute Infection, is active but no longer recruiting, sponsored by MeMed Diagnostics.

ACTIVE NOT RECRUITING
Registry status
2,000 participants
Enrollment target
8
Study locations

Study Summary

The study is a multi-center, prospective, observational clinical study enrolling patients from at least 3 medical centers. Study population will include patients over the age of 18 years. The study will recruit patients presenting with suspicion of acute infection/sepsis and healthy individuals. Study main objective is to derive and verify a host response based score to predicte severe outcome.

Conditions Studied

Study Locations (8)

Other

  • Carmel MC - Haifa
  • Rambam MC - Haifa
  • Edith Wolfson MC - Holon
  • Shaare Zedek MC - Jerusalem
  • Beilinson MC - Petah Tikva
  • Sheba Tel-HaShomer MC - Tel Aviv

New York

  • Maimonides MC - New York

Wisconsin

  • MCW - Milwaukee

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2020-11-12
Est. Completion 2025-12-31

Sponsor

MeMed Diagnostics

4 total trials

What the Registry Record Tells You About NCT06665542

The ClinicalTrials.gov registry entry for NCT06665542 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,542-participant average among 90 other Sepsis trials with a reported enrollment target (69% lower). The listed sponsor is MeMed Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sepsis appearing as the primary indexed condition, and to 0 interventions.

NCT06665542 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06665542 about?

NCT06665542 is a clinical study titled "A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.". The study is a multi-center, prospective, observational clinical study enrolling patients from at least 3 medical centers. Study population will include patients over the age of 18 years. The study will recruit patients presenting with suspicion of acute infection/sepsis and healthy individuals. S...

What is the current status of trial NCT06665542?

This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2020-11-12. Estimated completion is 2025-12-31.

What conditions does trial NCT06665542 study?

This clinical trial studies the following conditions: Sepsis, Acute Infection.

Who is sponsoring clinical trial NCT06665542?

This trial is sponsored by MeMed Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06665542 being conducted?

This trial has 8 study locations across New York, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sepsis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.